Clare Market Investments’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-3,110
Closed -$225K – 151
2025
Q1
$225K Sell
3,110
-324
-9% -$23.2K 0.06% 122
2024
Q4
$254K Hold
3,434
– – 0.06% 127
2024
Q3
$227K Buy
3,434
+700
+26% +$50.9K 0.06% 141
2024
Q2
$253K Buy
2,734
+124
+5% +$11K 0.07% 122
2024
Q1
$249K Buy
+2,610
New +$219K 0.08% 132
2023
Q3
– Sell
-2,760
Closed -$260K – 138
2023
Q2
$260K Hold
2,760
– – 0.1% 104
2023
Q1
$228K Hold
2,760
– – 0.1% 106
2022
Q4
$206K Hold
2,760
– – 0.1% 119
2022
Q3
$228K Hold
2,760
– – 0.1% 116
2022
Q2
$262K Sell
2,760
-1,200
-30% -$124K 0.11% 106
2022
Q1
$466K Sell
3,960
-300
-7% -$33.7K 0.15% 84
2021
Q4
$552K Hold
4,260
– – 0.15% 75
2021
Q3
$482K Hold
4,260
– – 0.14% 80
2021
Q2
$441K Hold
4,260
– – 0.14% 77
2021
Q1
$356K Sell
4,260
-900
-17% -$76.1K 0.13% 84
2020
Q4
$471K Hold
5,160
– – 0.2% 60
2020
Q3
$412K Hold
5,160
– – 0.2% 62
2020
Q2
$357K Hold
5,160
– – 0.21% 57
2020
Q1
$324K Sell
5,160
-1,050
-17% -$75.7K 0.27% 55
2019
Q4
$483K Hold
6,210
– – 0.35% 55
2019
Q3
$455K Buy
6,210
+405
+7% +$28.4K 0.43% 46
2019
Q2
$357K Sell
5,805
-600
-9% -$36.3K 0.28% 67
2019
Q1
$408K Buy
6,405
+1,155
+22% +$65.9K 0.36% 64
2018
Q4
$268K Buy
+5,250
New +$266K 0.35% 57

Other funds holding EW

Clare Market Investments's EW Position: Q2 2025 in Review

Clare Market Investments sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 3,110 shares — an estimated $225K sold.

Clare Market Investments first reported a position in EW in Q4 2018 and held it in 24 quarters. The position peaked at $552K in Q4 2021. 1,261 funds tracked by Wall St. Rank hold EW as of Q2 2025.

  • Clare Market Investments reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
  • Clare Market Investments sold 3,110 Edwards Lifesciences shares in Q2 2025, an estimated $225K.
  • Clare Market Investments first reported a position in Edwards Lifesciences in Q4 2018 and held it in 24 quarters.
  • Clare Market Investments's Edwards Lifesciences position peaked at $552K in Q4 2021.
  • 1,261 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Clare Market Investments's 13F filing for Q2 2025, filed 10 Jul 2025.